Santeri has over 15 years of experience in biomedical business development and R&D, from C-level at FenoMark Diagnostics AB and FIT Biotech Oy to research at Yale Medical School, Karolinska Institutet, and KU Leuven, among others. He has managed most aspects of life science product development, including market research and intelligence, product pipeline development and management, IP strategy, business strategy, as well as general management. Santeri holds a PhD in Biomedical Sciences and a BSc in Economics and Business Administration.